Aminoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands
Details for Australian Patent Application No. 2002304358 (hide)
International Classifications
Event Publications
19 December 2002 Complete Application Filed
Priority application(s): P01 02279 31.05.01 HU; P02 00774 01.03.02 HU
8 May 2003 Application Open to Public Inspection
Published as AU-B-2002304358
13 January 2005 Assignment before Grant
Sanofi-Synthelabo The application has been assigned to Sanofi-Aventis
17 February 2005 Change of Name(s) of Applicant(s), Section 104
Sanofi-Synthelabo The name of the applicant has been changed to Sanofi-Aventis Change of Name(s) of Applicant(s), Section 104
23 August 2007 Application Accepted
Published as AU-B-2002304358
20 December 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser